Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-29

FDA Approved: MICAFUNGIN — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s original ANDA for micafungin, a generic antifungal. The approval covers indications including candidiasis and related Candida …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN)